SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Guggenheim Maintains Buy Rating on Tenet Healthcare, Cuts Target to $306

Guggenheim maintained its Buy rating on Tenet Healthcare and cut its price target to $306 per share from $307.

THC

Related stories